Application of survival analysis methodology to the quantitative analysis of LC-MS proteomics data

Bioinformatics

Volumn 28, Issue 15, 2012, Pages 1998-2003

  Tekwe, Carmen D ^a   Carroll, Raymond J ^a   Dabney, Alan R ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN;

ARTICLE; COMPUTER PROGRAM; COMPUTER SIMULATION; DIABETES MELLITUS; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; NONPARAMETRIC TEST; PROTEOMICS; STATISTICAL MODEL; TANDEM MASS SPECTROMETRY;

CHROMATOGRAPHY, LIQUID; COMPUTER SIMULATION; DIABETES MELLITUS; HUMANS; LIKELIHOOD FUNCTIONS; MASS SPECTROMETRY; MODELS, STATISTICAL; PROTEINS; PROTEOMICS; SOFTWARE; STATISTICS, NONPARAMETRIC; TANDEM MASS SPECTROMETRY;

EID: 84865108718     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/bts306     Document Type: Article

References (32)

1. Aebersold,R. and Mann,M. (2003) Mass spectrometry-based proteomics, Nature, 422, 198-207.
2. Bach-Ngohou,K. et al. (2002) Apolipoprotein E kinetics: influence of insulin resistance and type 2 diabetes. Int. J. Obes., 26, 1451-1458.
3. Benjamini,Y. and Hochberg,Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing, J. R. Stat. Soc. B, 57, 289-300.
4. Collete,D. (2003) Modelling Survival Data in Medical Research, 2nd edn., Chapman & Hall/CRC, New York.
5. Cui,X. and Churchill,G.A. (2003) Statistical tests for differential expression in cDNA microarray experiments, Genome Biol., 4, 210.
6. Callister,S.J. and Barry,R.C. et al. (2006) Normalization approaches for removing systematic biases associated with mass spectrometry and label-free proteomics. J. Proteome Res., 5, 277-286.
7. Daimon,M. et al. (2011) Association of the clustering gene polymorphisms with type 2 diabetes mellitus. Metabolism, 60, 815-822.
8. deVera,I.E. et al. (2006) Clinical proteomics: the promises and challenges of mass spectrometry-based biomarker discovery. Clin. Adv. Hematol. Oncol., 4, 541-549.
9. Dicker,L. et al. (2010) Increased power for the analysis of label-free LC-MS/MS proteomics data by combining spectral counts and peptide peak attribution. Mol. Cell. Proteomics, 9, 2704-2718.
10. Hendrickson,E.L. et al. (2006) Comparison of spectral counting and metabolic stable isotope labeling for use with quantitative microbial proteomics. Analyst, 131, 1335- 1341.
11. Hollander,J. andWolfe,D.A. (1999) Nonparametric Statistical Methods, 2nd edn.Wiley Interscience, New York.
12. Jornsten,R. et al. (2005) DNA microarray data imputation and significance analysis of differential expression. Bioinformatics, 21, 4155-4161.
13. Karpievitch,Y. et al. (2009)Astatistical framework for protein quantitation in bottom-up MS-based proteomics. Bioinformatics, 25, 2028-2034.
14. Karpievitch,Y.V. et al. (2010) Liquid chromatography mass spectrometry-based proteomics: biological and technical aspects. Ann. Appl. Stat., 4, 1797-1823.
15. Klein,J.P. and Moeschberger,M.L. (2003) Survival Analysis: Techniques for Censored and Truncated Data, 2nd edn., Springer, New York.
16. Kiebel,G. et al. (2006) PRISM: a data management system for high-throughput proteomics. Proteomics, 6, 1783-1790.
17. Little,R.J.A. and Rubin,D.B.(2002) Statistical Analysis with Missing Data, 2nd edn. Wiley Interscience, New York.
18. Metz,T.O. et al. (2008) Application of proteomics in the discovery of candidate protein biomarkers in a diabetes autoantibody standardization program sample subset. J. Proteome Res., 7, 698-707.
19. Oba,S. et al. (2003) A Bayesian missing value estimation method for gene expression profile data. Bioinformatics, 19, 2088-2096.
20. Odell,P.M. et al. (1992) Maximum likelihood estimation for interval-censored data using a Weibull-based accelerated failure time model. Biometrics, 48, 951-959.
21. Ouyang,M. et al. (2004) Gaussian mixture clustering and imputation of microarray data. Bioinformatics, 20, 917-923.
22. Pasa-Tolic,L. et al. (2004) Proteomic analyses using an accurate mass and time tag strategy. BioTechniques, 37, 621-636.
23. Piao,Z. et al. (2011) Statistical optimization of parametric accelerated failure timemodel for mapping survival trait loci. Theor. Appl. Genet., 122, 855-863.
24. Polpitiya,A.D. et al. (2008) DAnTE: a statistical tool for quantitative analysis of -omics data. Bioinformatics, 24, 1556-1558.
25. Renno,W.M. et al. (2006) Talin immunogold density increases in sciatic nerve of diabetic rats after nerve growth factor treatment. Mediciana (Kaunas), 42, 147-163.
26. Stacklies,W. et al. (2007) pcaMethods-a bioconductor package providing PCAmethods for incomplete data. Bioinformatics, 23, 9.
27. Storey,J.D. (2002) A direct approach to false discovery rates. J.R. Stat. Soc. B, 64, 479-498.
28. Thygeson,H.H. and Zwinderman,A.H. (2004) Comparing transformation methods for DNA microarray data. BMC Bioinformatics, 5, 77.
29. Troyanskaya,O. et al. (2001) Missing value estimation methods for DNA microarrays. Bioinformatics, 17, 520-525.
30. Vogel,C. and Marcotte,E. (2008) Calculating absolute and relative protein abundance from mass spectrometry-based protein expression data. Nat. Protoc., 3, 1441-1451.
31. Zimmer,M.E. et al. (2006) Advances in proteomics data analysis and display using an accurate mass and time tag strategy. Mass Spectrom. Rev., 23, 450-482.
32. Zhu,W. et al. (2009) Mass spectrometry-based label-free quantitative proteomics, J. Biom. Biotechnol., 2010, 840518.